Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin.

Giustina, A; Girelli, A; Buffoli, M G; Cimino, A; Legati, F; Valentini, U; Giustina, G

Giustina, A; Girelli, A; Buffoli, M G; Cimino, A; Legati, F; Valentini, U; Giustina, G.

Affiliation

Giustina A; Cattedra di Clinica Medica, University of Brescia, Italy.

Diabetes Res Clin Pract ; 14(1): 47-54, 1991 Oct.

Article in En | MEDLINE | ID: mdl-1748062

Subject(s)

Blood Glucose/metabolism; Diabetes Mellitus, Type 2/physiopathology; Eating; Insulin/therapeutic use; Octreotide/pharmacology; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Drug Administration Schedule; Drug Interactions; Female; Humans; Insulin/administration & dosage; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Octreotide / Diabetes Mellitus, Type 2 / Eating / Insulin Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Res Clin Pract Journal subject: ENDOCRINOLOGIA Year: 1991 Document type: Article Affiliation country: Italy Country of publication: Ireland

Search on Google

Add to My VHL

XML

PubMed Links